Results 111 to 120 of about 258,688 (126)
Some of the next articles are maybe not open access.

Traumatic brain injury in mice and pentadecapeptide BPC 157 effect

Regulatory Peptides, 2010
Gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, an anti-ulcer peptide, efficient in inflammatory bowel disease trials (PL 14736), no toxicity reported, improved muscle crush injury. After an induced traumatic brain injury (TBI) in mice by a falling weight, BPC 157 regimens (10.0microg, 10.0ng/kgi.p.) demonstrated a marked attenuation of damage with ...
Tudor, Mario   +11 more
openaire   +3 more sources

Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula

European Journal of Pharmacology, 2016
To establish the effects of BPC 157 on the healing of rat colovesical fistulas, Wistar Albino male rats were randomly assigned to different groups. BPC 157, a stable gastric pentadecapeptide, has been used in clinical applications-specifically, in ulcerative colitis-and was successful in treating both external and internal fistulas.
Grgić, Tihomir   +10 more
openaire   +2 more sources

The Role of Pentadecapeptide BPC 157 in angiogenesis and NO-synthesis

1997
A clear protection of G-I tract and an evident anti-inflammatory effect were shown for a novel stomach pentadecapeptide BPC(i.p./i.g.) in comparison with several reference standards in various ulcer models alog with a protection of endothelium. Thus, in the first experiments we evaluated whether this pentadecapeptide and other gastroprotective agents ...
Sikirić, Predrag   +18 more
openaire   +2 more sources

Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats

Life Sciences, 2016
Rectovaginal fistula is a devastating condition providing more than 99% of patients for surgical treatment. We hypothesized that rectovaginal fistula may be healed by therapy with stable gastric pentadecapeptide BPC 157, in consistence with its initial clinical application and effect on external fistulas.BPC 157 (10μg/kg or 10ng/kg) was given perorally,
Barić, Marko   +10 more
openaire   +3 more sources

Pentadecapeptide BPC 157 and head injury

2004
Pentadecapeptide BPC 157 and head ...
openaire  

Effects of pentadecapeptide BPC-157 on rat calvarial bicortical defects

2003
Gastric pentadecapeptide BPC-157 (currently in clinical phase II for inflammatory bowel disease) was tested in 7 mm diameter surgically created defects of rat calvaria. Insufficient or absence of bone healing is a frequent problem within all surgical fields.
Dobric, Ivan   +16 more
openaire   +2 more sources

The effect 0f Pentadecapeptide BPC 157 on succynilcholine and NO system

2014
we tested in living rats the hypothesis that the succinylcholine local and systemic threatening effect should depend on NO related mechanisms.
Katančić Holjevac, J   +11 more
openaire   +2 more sources

Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
Using duodenocolic fistula in rats, this study attempts to highlight the particular cytoprotection aspects of the healing of fistulas and therapy potential of the stable gastric pentadecapeptide BPC 157, a cytoprotection mediator (i.e. upgrading minor vessels to induce healing at both fistula's sides).
D, Vukusic   +17 more
openaire   +2 more sources

Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma

Biomedicines, 2022
Tamara Kralj   +2 more
exaly  

Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2009
Previously, the gastric pentadecapeptide BPC 157, (PL 14736, Pliva) has been shown to have several beneficial effects, it exert gastroprotective, anti-inflammatory actions, stimulates would healing and has therapeutic value in inflammatory bowel disease.
Boban Blagaić, Alenka   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy